WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2018053368) NANOPARTICLES AS CATALYTIC SUBSTRATES FOR REAL-TIME BIOSENSING OF HUMAN PERFORMANCE AND DIAGNOSTIC AND THERAPEUTIC METHODS
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.:    WO/2018/053368    International Application No.:    PCT/US2017/051930
Publication Date: 22.03.2018 International Filing Date: 15.09.2017
IPC:
G01N 33/92 (2006.01), G01N 33/68 (2006.01), C12Q 1/48 (2006.01), A61K 9/51 (2006.01)
Applicants: NORTHWESTERN UNIVERSITY [US/US]; 633 Clark Street Evanston, IL 60208 (US)
Inventors: THAXTON, C., Shad; (US).
PALEKAR, Rohun, U.; (US).
MCMAHON, Kaylin, M.; (US)
Agent: LOCKHART, Helen, C.; (US)
Priority Data:
62/395,245 15.09.2016 US
Title (EN) NANOPARTICLES AS CATALYTIC SUBSTRATES FOR REAL-TIME BIOSENSING OF HUMAN PERFORMANCE AND DIAGNOSTIC AND THERAPEUTIC METHODS
(FR) NANOPARTICULES SERVANT DE SUBSTRATS CATALYTIQUES POUR LA BIODÉTECTION EN TEMPS RÉEL DE PERFORMANCES HUMAINES, ET PROCÉDÉS DE DIAGNOSTIC ET THÉRAPEUTIQUES
Abstract: front page image
(EN)Nanostructures having an inorganic core and a lipid layer capable of binding a lecithinxholesterol acyltransferase (LCAT) activator such as an apolipoprotein are provided herein. Methods of using the nanostructures and related devices and compositions for assessing the risk of developing a disease or condition or treating the disease or condition are also provided.
(FR)L'invention concerne des nanostructures ayant un noyau inorganique et une couche lipidique capable de se lier à un activateur de lécithine cholestérol acyl transférase (LCAT) telle qu'une apolipoprotéine. L'invention concerne également des procédés d'utilisation des nanostructures et de dispositifs et compositions associés pour évaluer le risque de développer une maladie ou un état ou pour traiter la maladie ou l'état.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)